Ramdas Borhade: IL-17, Endothelial Activation and Thrombosis Prediction in Cancer
Ramdas Borhade, Deputy General Manager at Murali Krishna Pharma PVT LTD, shared on LinkedIn about a recent article by Dimitra Karagkouni et al, published in Science Translational Medicine, adding:
”Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation | Science Translational Medicine.”
Title: Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation
Authors: Dimitra Karagkouni, Marisa A. Brake, Rushad Patell, Anna Falanga, Marina Marchetti, Laura Russo, Simon Mantha, Donna Neuberg, Thita Chiasakul, Marc Carrier, Philip S. Wells, Robert E. Gerszten, Robert Flaumenhaft, Daniel Hui, Ioannis S. Vlachos, Sol Schulman, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 19, 2026, 16:24Paritosh Garg: Management of ITP in Pregnancy – What Changed My Practice?
-
Jun 19, 2026, 15:16Jecko Thachil: The Overlooked Impact of Iron Deficiency Without Anaemia
-
Jun 19, 2026, 15:05Arthur Allen: The Evolving Role of Anticoagulation Programs in Modern Cardiovascular Care
-
Jun 19, 2026, 15:02Recognizing the Strength and Resilience of People Living with Sickle Cell Disease – Mass General Brigham
-
Jun 19, 2026, 14:44Cedric Hermans: The Impact Factor of Haemophilia Remains an Encouraging Achievement
-
Jun 19, 2026, 14:28Severiano Dos Anjos Vilaboa: The Search for the Optimal PRP Strategy
-
Jun 19, 2026, 14:05David McIntosh: The Lifesaving Role of Blood Donation in Maternal Care
-
Jun 19, 2026, 13:45Isaac Okello: A National Call to Action on World Sickle Cell Day 2026
-
Jun 19, 2026, 11:52Hemant Pathare: Could Genetic Screening Change the Future of SCD?